Try our mobile app
Screener
Company
Price and
change
Revenue Growth
last / hist
EV /
LTM
EBITDA
(p75)
EV/
Sales
EBITDA LTM
/ Revenue
FCF LTM
/ Revenue
Next GAAP report
Year div-d yield
FCF Yield LTM
Trending screeners:
@electric-vehicles
@saas
@cannabis-players
@china
Latin America
India
Dividends
@REITs
@adtech
@airlines
@artificial-intelligence
@auto-parts
@cloud-computing
@crypto
@cybersecurity
@e-commerce
@edtech
@finance-and-technology
@gaming
@internet-of-things
@oil-refining
@real-estate-tech
@renewable-energy
@vaccine-makers

Reviews

2024-05-07
#reports #WAT

[Waters](https://eninvs.com/all.php?name=WAT) (Research instrument manufacturer) reported for [2024 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=167916)
(2024-05-07, Before Market Open):

- Revenue -7.0% YoY (vs -4.7% in previous quarter and historical rate +5.7%)
- EBITDA -11.2% YoY (vs -1.9% in previous quarter and historical rate +3.6%)
- EBITDA margin 28.6% decreased compared to 29.9% same period last year
- Net Debt decreased by $151.0 mln over the past reporting period (0.8% of market cap)
- FCF (LTM) -$0.8 bln (negative), 4.3% of market cap
- EV/EBITDA multiple is 21.6x compared to historical level (75th percentile) of 22.4x
- EV/Sales multiple is 7.1x

The company showed EPS +$1.72 per share. At the opening of the session the share price went down -0.1% vs S&P500 +0.1%
2024-05-07
#reports #UE

[Urban Edge Properties](https://eninvs.com/all.php?name=UE) (REIT — Diversified) reported for [2024 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=167913)
(2024-05-07, Before Market Open):

- Revenue +11.1% YoY (vs +14.7% in previous quarter and historical rate +10.4%)
- EBITDA +200.0% YoY (vs +40.8% in previous quarter and historical rate +40.9%)
- EBITDA margin 54.5% increased compared to 20.2% same period last year
- EV/EBITDA multiple is 8.5x compared to historical level (75th percentile) of 17.1x
- EV/Sales multiple is 4.7x

At the opening of the session the share price went up +2.5% vs S&P500 +0.1%
2024-05-07
#reports #TACT

[TransAct Technologies](https://eninvs.com/all.php?name=TACT) (Computer Hardware) reported for 2024 q1
(2024-05-07, Before Market Open):

- Revenue -50.0% YoY (vs -27.8% in previous quarter and historical rate +38.5%)
- EBITDA -125.0% YoY (vs -50.0% in previous quarter)
- EBITDA margin -9.1% decreased compared to 18.2% same period last year
- Net Debt increased by $2.0 mln over the past reporting period (3.9% of market cap)
- FCF (LTM) +$0.0 bln (positive), 9.8% of market cap
- EV/EBITDA multiple is 6.6x compared to historical level (75th percentile) of 11.2x
- EV/Sales multiple is 0.7x

At the opening of the session the share price went down -21.2% vs S&P500 +0.1%
2024-05-07
#reports #STIM

[Neuronetics](https://eninvs.com/all.php?name=STIM) (Diagnostics and Research) reported for 2024 q1
(2024-05-07, Before Market Open):

- Revenue +6.3% YoY (vs +11.1% in previous quarter and historical rate +14.4%)
- EBITDA margin -35.3% increased compared to -56.3% same period last year
- Net Debt increased by $12.0 mln over the past reporting period (11.0% of market cap)
- FCF (LTM) -$0.0 bln (negative), 15.6% of market cap
- EV/Sales multiple is 1.7x

At the opening of the session the share price went down -24.3% vs S&P500 +0.1%
2024-05-07
#reports #SQSP

[Squarespace, Inc.](https://eninvs.com/all.php?name=SQSP) (Software — Infrastructure) reported for 2024 q1
(2024-05-07, Before Market Open):

- Revenue +18.6% YoY (vs +18.3% in previous quarter and historical rate +14.3%)
- EBITDA -55.6% YoY (vs +3600.0% in previous quarter and historical rate +47.5%)
- EBITDA margin 1.4% decreased compared to 3.8% same period last year
- Net Debt decreased by $968.0 mln over the past reporting period (19.7% of market cap)
- FCF (LTM) -$0.0 bln (negative), 0.2% of market cap
- EV/EBITDA multiple is 44.1x compared to historical level (75th percentile) of 237.1x
- EV/Sales multiple is 5.0x

At the opening of the session the share price went up +2.8% vs S&P500 +0.1%
2024-05-07
#reports #SPR

[Spirit AeroSystems](https://eninvs.com/all.php?name=SPR) (Commercial aircraft structures manufacturer) reported for 2024 q1
(2024-05-07, Before Market Open):

- Revenue +19.0% YoY (vs +37.3% in previous quarter and historical rate +25.7%)
- EBITDA margin -26.3% decreased compared to -1.0% same period last year
- Net Debt increased by $456.0 mln over the past reporting period (12.4% of market cap)
- FCF (LTM) -$0.0 bln (negative), 0.5% of market cap
- EV/Sales multiple is 1.2x

At the opening of the session the share price went down -1.4% vs S&P500 +0.1%
2024-05-07
#reports #SNCY

[Sun Country Airlines Holdings, Inc.](https://eninvs.com/all.php?name=SNCY) (Airlines) reported for [2024 q1](https://eninvs.com/press_release.php?ticker=SNCY&q=2024 q1&id=778801)
(2024-05-06, Before Market Open):

- Revenue +14.8% YoY (vs +21.2% in previous quarter and historical rate +40.9%)
- EBITDA +2.6% YoY (vs +17.1% in previous quarter and historical rate +53.8%)
- EBITDA margin 25.4% decreased compared to 28.4% same period last year
- EV/EBITDA multiple is 3.2x compared to historical level (75th percentile) of 12.6x
- EV/Sales multiple is 0.7x

The company showed EPS +$0.64 per share. At the opening of the session the share price went up +0.7% vs S&P500 +0.3%
2024-05-07
#reports #SCSC

[ScanSource](https://eninvs.com/all.php?name=SCSC) (Scanner supplier) reported for 2024 q1
(2024-05-07, Before Market Open):

- Revenue -15.0% YoY (vs -12.5% in previous quarter and historical rate +23.3%)
- EBITDA -39.0% YoY (vs -26.1% in previous quarter and historical rate +52.2%)
- EBITDA margin 3.3% decreased compared to 4.6% same period last year
- Net Debt decreased by $137.0 mln over the past reporting period (12.4% of market cap)
- FCF (LTM) +$0.2 bln (positive), 13.6% of market cap
- EV/EBITDA multiple is 5.4x compared to historical level (75th percentile) of 7.1x
- EV/Sales multiple is 0.2x

At the opening of the session the share price went up +6.4% vs S&P500 +0.1%
2024-05-07
#reports #RYTM

[Rhythm Pharmaceuticals](https://eninvs.com/all.php?name=RYTM) (Molecular drug manufacturer) reported for 2024 q1
(2024-05-07, Before Market Open):

- Revenue +136.4% YoY (vs +166.7% in previous quarter and historical rate +175.3%)
- EBITDA margin -534.6% decreased compared to -472.7% same period last year
- Net Debt increased by $74.0 mln over the past reporting period (2.8% of market cap)
- FCF (LTM) -$0.0 bln (negative), 0.7% of market cap
- EV/Sales multiple is 26.1x

At the opening of the session the share price went down -13.7% vs S&P500 +0.1%
2024-05-07
#reports #PMTS

[CPI Card Group](https://eninvs.com/all.php?name=PMTS) (Credit Services) reported for [2024 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=167909)
(2024-05-07, Before Market Open):

- Revenue -7.4% YoY (vs -18.3% in previous quarter and historical rate +13.4%)
- Net Income -54.5% YoY (vs -75.0% in previous quarter and historical rate +46.7%)
- Net Income margin 4.5% decreased compared to 9.1% same period last year
- P/E multiple is 11.2x compared to historical level (75th percentile) of 9.0x
- P/S multiple is 0.5x
- Price to book: -4.0x

At the opening of the session the share price went up +2.1% vs S&P500 +0.1%
2024-05-07
#reports #OTTR

[Otter Tail](https://eninvs.com/all.php?name=OTTR) (Energy provider) reported for 2024 q1
(2024-05-06, After Market Close):

- Revenue +2.4% YoY (vs +4.3% in previous quarter and historical rate +16.5%)
- EBITDA +15.2% YoY (vs +21.8% in previous quarter and historical rate +33.3%)
- EBITDA margin 34.9% increased compared to 31.0% same period last year
- Net Debt increased by $30.0 mln over the past reporting period (0.8% of market cap)
- FCF (LTM) +$0.1 bln (positive), 2.0% of market cap
- EV/EBITDA multiple is 9.5x compared to historical level (75th percentile) of 10.3x
- EV/Sales multiple is 3.3x

At the opening of the session the share price went up +5.3% vs S&P500 +0.1%
2024-05-07
#reports #OSCR

[Oscar Health, Inc.](https://eninvs.com/all.php?name=OSCR) (Healthcare Plans) reported for 2024 q1
(2024-05-07, Before Market Open):

- Revenue +45.7% YoY (vs +43.9% in previous quarter and historical rate +85.8%)
- Net Income margin 8.3% increased compared to -2.7% same period last year
- P/S multiple is 0.6x
- Price to book: 5.2x

At the opening of the session the share price went up +4.1% vs S&P500 +0.1%
2024-05-07
#reports #OFIX

[Orthofix Medical](https://eninvs.com/all.php?name=OFIX) (Medical equipment manufacturer) reported for [2024 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=167925)
(2024-05-07, Before Market Open):

- Revenue +8.0% YoY (vs +63.9% in previous quarter and historical rate +27.2%)
- EBITDA margin -5.8% increased compared to -32.0% same period last year
- EV/Sales multiple is 0.7x

At the opening of the session the share price went down -2.3% vs S&P500 +0.1%
2024-05-07
#reports #NRG

[NRG Energy](https://eninvs.com/all.php?name=NRG) (Energy services provider) reported for 2024 q1
(2024-05-07, Before Market Open):

- Revenue -3.8% YoY (vs -50.4% in previous quarter and historical rate +46.1%)
- EBITDA margin 15.3% increased compared to -17.5% same period last year
- Net Debt decreased by $358.0 mln over the past reporting period (1.9% of market cap)
- FCF (LTM) +$0.9 bln (positive), 4.7% of market cap
- EV/EBITDA multiple is 7.5x compared to historical level (75th percentile) of 7.5x
- EV/Sales multiple is 1.0x

At the opening of the session the share price went up +4.8% vs S&P500 +0.1%
2024-05-07
#reports #NOVT

[Novanta](https://eninvs.com/all.php?name=NOVT) (Scientific and Technical Instruments) reported for 2024 q1
(2024-05-07, Before Market Open):

- Revenue +5.5% YoY (vs -2.8% in previous quarter and historical rate +15.0%)
- EBITDA +2.6% YoY (vs -15.4% in previous quarter and historical rate +17.7%)
- EBITDA margin 16.9% decreased compared to 17.4% same period last year
- Net Debt increased by $176.0 mln over the past reporting period (3.0% of market cap)
- FCF (LTM) -$0.1 bln (negative), 1.4% of market cap
- EV/EBITDA multiple is 40.3x compared to historical level (75th percentile) of 45.2x
- EV/Sales multiple is 7.0x

At the opening of the session the share price went up +2.3% vs S&P500 +0.1%
2024-05-07
#reports #NJR

[New Jersey Resources Corporation](https://eninvs.com/all.php?name=NJR) (Energy company) reported for 2024 q1
(2024-05-07, Before Market Open):

- Revenue +2.2% YoY (vs -35.5% in previous quarter and historical rate +4.0%)
- EBITDA +3.4% YoY (vs -15.4% in previous quarter and historical rate +10.9%)
- EBITDA margin 31.9% increased compared to 31.5% same period last year
- EV/EBITDA multiple is 8.2x compared to historical level (75th percentile) of 15.9x
- EV/Sales multiple is 2.5x

At the opening of the session the share price went down -0.4% vs S&P500 +0.1%
2024-05-07
#reports #MKTX

[MarketAxess](https://eninvs.com/all.php?name=MKTX) (Bond trading platform) reported for 2024 q1
(2024-05-07, Before Market Open):

- Revenue +3.4% YoY (vs +10.7% in previous quarter and historical rate +2.1%)
- Net Income -1.4% YoY (vs +18.6% in previous quarter and historical rate -14.6%)
- Net Income margin 34.8% decreased compared to 36.5% same period last year
- P/E multiple is 30.5x compared to historical level (75th percentile) of 36.9x
- P/S multiple is 10.2x
- Price to book: 6.0x

At the opening of the session the share price went up +1.5% vs S&P500 +0.1%
2024-05-07
#reports #ITCI

[Intra-Cellular Therapies](https://eninvs.com/all.php?name=ITCI) (Small molecular drugs manufacturer) reported for 2024 q1
(2024-05-07, Before Market Open):

- Revenue +52.6% YoY (vs +50.0% in previous quarter and historical rate +139.9%)
- EBITDA margin -13.8% increased compared to -49.5% same period last year
- Net Debt increased by $8.0 mln over the past reporting period (0.1% of market cap)
- FCF (LTM) +$0.1 bln (positive), 1.1% of market cap
- EV/Sales multiple is 12.8x

At the opening of the session the share price went down -2.5% vs S&P500 +0.1%
2024-05-07
#reports #GOLF

[Acushnet](https://eninvs.com/all.php?name=GOLF) (Golf products supplier) reported for 2024 q1
(2024-05-07, Before Market Open):

- Revenue +3.2% YoY (vs -7.6% in previous quarter and historical rate +13.3%)
- EBITDA -2.9% YoY (vs -163.6% in previous quarter and historical rate +8.9%)
- EBITDA margin 18.9% decreased compared to 20.1% same period last year
- Net Debt increased by $177.0 mln over the past reporting period (4.3% of market cap)
- FCF (LTM) +$0.1 bln (positive), 3.3% of market cap
- EV/EBITDA multiple is 16.2x compared to historical level (75th percentile) of 14.2x
- EV/Sales multiple is 2.1x

At the opening of the session the share price went up +4.1% vs S&P500 +0.1%
2024-05-07
#reports #FWRG

[First Watch Restaurant Group, Inc.](https://eninvs.com/all.php?name=FWRG) (Restaurants) reported for [2024 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=167907)
(2024-05-07, Before Market Open):

- Revenue +14.7% YoY (vs +31.7% in previous quarter and historical rate +33.7%)
- EBITDA +4.2% YoY (vs -1200.0% in previous quarter and historical rate +29.2%)
- EBITDA margin 10.3% decreased compared to 11.4% same period last year
- EV/EBITDA multiple is 34.4x compared to historical level (75th percentile) of 59.9x
- EV/Sales multiple is 2.2x

At the opening of the session the share price went down -12.7% vs S&P500 +0.1%
2024-05-07
#reports #ESPR

[Esperion Therapeutics](https://eninvs.com/all.php?name=ESPR) (Medical device manufacturer) reported for 2024 q1
(2024-05-07, Before Market Open):

- Revenue +475.0% YoY (vs +68.4% in previous quarter and historical rate +60.5%)
- EBITDA margin 52.2% increased compared to -204.2% same period last year
- EV/Sales multiple is 1.6x

At the opening of the session the share price went up +14.6% vs S&P500 +0.1%